DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Nissen SE, Wolski K.
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.
N Engl J Med 2007;
356: 2457-2471
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.